Email Us
View Reports

Biomarker Technologies Market

Biomarker Technologies Market Analysis - By Product (Consumables, Assay, Reagent and Instruments), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay and Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), By Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Industry Size, Share, Trends, Growth and Global Forecast to 2026

  • ID : 97423871  |  
  • Published : Jun-2019  |  
  • Region : Global  |  
  • Pages : 150   |  
  • Publisher : Research Cosmos

Biomarker Technologies Market Size and Growth Rate – (2019 - 2026)

As per our latest report, the size of the Global Biomarker Technologies Market will reach USD 58.5 Billion by the end of 2026, witnessing a CAGR of 13.2% from 2019 to 2026. Biomarker indicates the state of the disease of a particular organism. It measures the severity of the disease by examining the function of the organs in the body. Biomarkers also serve complex organ function or changes in the biological structures. With the help of these technologies, the patient could get better treatment as it specifies how the patient will respond to different drugs.

Market Dynamics:

  • Rising initiative steps by the government like launching reimbursement schemes in favor of the common people is considered to be the main factor propelling the demand of the market. Additionally, the market is escalated by the growing prevalence of chronic diseases due to changes in the lifestyle and increasing demand for effective treatment procedures.
  • However, the cost for installation and maintenance of the equipment are little high which is restricting the growth of the market.  Lack of treatment facilities in rural areas is also impacting negatively on the growth of this market.
  • Increasing construction of hospitals and clinics everywhere is creating chances for the market. The rise in the acceptance of the latest technological developments and introduction of various devices in favor to the end-user industry is solely lavishing growth opportunities for the market. Growing research institutes in the biotechnology field are also bolstering the demand of the market.

Based on the product type, the market is bifurcated into consumables, instruments, services, and software. The consumables segment is leading with the highest shares of the market.

By the research area, the market categories are genomics, proteomics, metabolisms, metabolic flux, lipidomic and others. Among all, genomics is accounted with the highest CAGR in the coming years.

Biomarker Technologies Market was dominated by the APAC region in 2018

Geographically, the biomarker technologies market is led by Asia pacific by owing to rising geriatric population and also launch of new devices to promote health benefits. North America is positioned second in leading the shares of the market. The rise in the adoption of advanced technologies is mainly boosting up the demand of the market in this region. Europe is anticipated to have a significant growth rate in the future period. Middle East & Africa had few growth opportunities in the past years and with the growing awareness programs, the market is deemed to have active growth rate in the near future.

Some of the key competitors of the market are:

  • Agilent Technologies (US)
  • Thermo Fisher Scientific (US)
  • Roche (Switzerland)
  • Waters Corporation (US)
  • Danaher Corporation (US)
  • Shimadzu Corporation (Japan)
  • Bio-Rad Laboratories (US)

This research report includes following segmentation for the Global Biomarker Technologies Market size and forecast until 2025.

Biomarker Technologies Market Analysis - By Product 

  • Consumables
  • Assay
  • Reagent
  • Instruments

Biomarker Technologies Market Analysis - By Technology

  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Immunoassay
  • Others

Biomarker Technologies Market Analysis - By Application

  • Drug Discovery
  • Diagnostics
  • Personalized Medicine

Biomarker Technologies Market Analysis - By Indication

  • Cancer 
  • Infectious Diseases
  • Autoimmune Disorders
  • Cardiovascular Disorders
  • Others

Biomarker Technologies Market Analysis - By Region 

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • France
    • UK
    • Italy 
    • Spain
    • Rest of Europe

  • Asia-Pacific

    • India
    • China
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific

  • LAMEA

    • Brazil
    • South Africa
    • Rest of LAMEA

Key takeaways from the report:

  • Analysis of the current and future trends and growth potential of the market during the forecast period
  • Evaluate market potential in terms of growth rates (CAGR), Value (USD) and Volume (Units) sales at country level across various segments of the market
  • Understand the market dynamics and key influencers in terms of driving factors and opportunities of the market. Also, restraints and challenges that the industry has to endure
  • Insights on competitor performance with a benchmarking analysis of their market position, financials and more
  • Profiles of key market players providing a comprehensive understanding of their product portfolio, SWOT analysis, and growth strategies
  • Information on key events in the recent past which includes mergers & acquisition, new product launches, collaborations, deals, and other agreements
  • Analysis of the supply-demand gap, import-export statistics, and other key market insights for more than 20 countries globally
  • Gauge the competition in the industry with Porter's five force analysis understanding the threat from new entrants and substitute products.
  • Understand the effects of macro-level environment factors through the PESTLE analysis, providing a detailed assessment of the external factors that have an impact on the industry

CHAPTER 1:    INTRODUCTION

1.1.    Report description

1.2.    Key market segments

1.2.1.    List of key players profiled in the report

1.3.    Research methodology

1.3.1.    Primary research

1.3.2.    Secondary research

1.3.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    KEY FINDINGS OF THE STUDY

2.2.    Key findings

2.2.1.    Top impacting factors

2.2.2.    Top investment pockets

2.3.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope

3.2.    Key Forces Shaping Biomarker technologies Industry/Market

3.2.1.    Moderate bargaining power of supplier

3.2.2.    Low bargaining power of buyers

3.2.3.    Low threat of substitutes

3.2.4.    High intensity of rivalry

3.2.5.    Low threat of new entrant

3.3.    Pricing Analysis

3.3.1.    Pricing Analysis of Biomarker technologies, By Region, 2018 & 2025

3.4.    Market evolution/Industry roadmap

3.5.    Value Chain Analysis

3.6.    Impact of government regulations on global biomarker technologies market

3.7.    Industry Pain point analysis

3.8.    Market dynamics

3.8.1.    Drivers

3.8.1.1.    Rise in prevalence of various diseases

3.8.1.2.    Surge in R&D activities in healthcare coupled with rise in adoption of early toxicity testing

3.8.1.3.    Advantages offered by biomarker in drug development

3.8.1.4.    Increase in genome mapping programs

3.8.2.    Restraints

3.8.2.1.    High initial capital investments required for biomarker discovery

3.8.2.2.    Lack of awareness regarding the use of biomarker technologies

3.8.3.    Opportunity

3.8.3.1.    High potential of the emerging economies

3.8.4.    Impact Analyses

CHAPTER 4:    BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT AND SERVICES

4.1.    Overview

4.2.    Consumables

4.2.1.    Key market trends, growth factors and opportunities

4.2.2.    Market size and forecast, by type

4.2.2.1.    Reagents

4.2.2.1.1.    Market size and forecast

4.2.2.2.    Assays

4.2.2.2.1.    Market size and forecast

4.2.3.    Market size and forecast, by region

4.2.4.    Market analysis by country

4.3.    Instruments

4.3.1.    Key market trends, growth factors, and opportunities

4.3.2.    Market size and forecast, by region

4.3.3.    Market analysis by country

CHAPTER 5:    BIOMARKER TECHNOLOGIES MARKET, BY TECHNOLOGY

5.1.    Overview

5.2.    Polymerase Chain Reaction (PCR)

5.2.1.    Market size and forecast, by region

5.2.2.    Market analysis by country

5.3.    Next Generation Sequencing  (NGS)

5.3.1.    Market size and forecast, by region

5.3.2.    Market analysis by country

5.4.    Immunoassay

5.4.1.    Market size and forecast, by region

5.4.2.    Market analysis by country

5.5.    Others

5.5.1.    Market size and forecast, by region

5.5.2.    Market analysis by country

CHAPTER 6:    BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION

6.1.    Overview

6.2.    Drug Discovery

6.2.1.    Market size and forecast, by region

6.2.2.    Market analysis by country

6.3.    Diagnostics

6.3.1.    Market size and forecast, by region

6.3.2.    Market analysis by country

6.4.    Personalized Medicine

6.4.1.    Market size and forecast, by region

6.4.2.    Market analysis by country

CHAPTER 7:    BIOMARKER TECHNOLOGIES MARKET, BY INDICATION

7.1.    Overview

7.2.    Cancer

7.2.1.    Market size and forecast, by region

7.2.2.    Market analysis by country

7.3.    Infectious Diseases

7.3.1.    Market size and forecast, by region

7.3.2.    Market analysis by country

7.4.    Autoimmune Disorders

7.4.1.    Market size and forecast, by region

7.4.2.    Market analysis by country

7.5.    Cardiovascular Disorders

7.5.1.    Market size and forecast, by region

7.5.2.    Market analysis by country

7.6.    Others

7.6.1.    Market size and forecast, by region

7.6.2.    Market analysis by country

CHAPTER 8:    BIOMARKER TECHNOLOGIES MARKET, BY REGION

8.1.    Overview

8.2.    North America

8.2.1.    Key market trends and opportunities

8.2.2.    Market analysis by country

8.2.2.1.    U.S.

8.2.2.1.1.    U.S. market size and forecast, by product and services

8.2.2.1.2.    U.S. market size and forecast, by technology

8.2.2.1.3.    U.S. market size and forecast, by application

8.2.2.1.4.    U.S. market size and forecast, by indication

8.2.2.2.    Canada

8.2.2.2.1.    Canada market size and forecast, by product and services

8.2.2.2.2.    Canada market size and forecast, by technology

8.2.2.2.3.    Canada market size and forecast, by application

8.2.2.2.4.    Canada market size and forecast, by indication

8.2.2.3.    Mexico

8.2.2.3.1.    Mexico market size and forecast, by product and services

8.2.2.3.2.    Mexico market size and forecast, by technology

8.2.2.3.3.    Mexico market size and forecast, by application

8.2.2.3.4.    Mexico market size and forecast, by indication

8.2.3.    North America market size and forecast, by product and services

8.2.4.    North America market size and forecast, by technology

8.2.5.    North America market size and forecast, by application

8.2.6.    North America market size and forecast, by indication

8.3.    Europe

8.3.1.    Key market trends and opportunities

8.3.2.    Market analysis by country

8.3.2.1.    Germany

8.3.2.1.1.    Germany market size and forecast, by product and services

8.3.2.1.2.    Germany market size and forecast, by technology

8.3.2.1.3.    Germany market size and forecast, by application

8.3.2.1.4.    Germany market size and forecast, by indication

8.3.2.2.    France

8.3.2.2.1.    France market size and forecast, by product and services

8.3.2.2.2.    France market size and forecast, by technology

8.3.2.2.3.    France market size and forecast, by application

8.3.2.2.4.    France market size and forecast, by indication

8.3.2.3.    UK

8.3.2.3.1.    UK market size and forecast, by product and services

8.3.2.3.2.    UK market size and forecast, by technology

8.3.2.3.3.    UK market size and forecast, by application

8.3.2.3.4.    UK market size and forecast, by indication

8.3.2.4.    Italy

8.3.2.4.1.    Italy market size and forecast, by product and services

8.3.2.4.2.    Italy market size and forecast, by technology

8.3.2.4.3.    Italy market size and forecast, by application

8.3.2.4.4.    Italy market size and forecast, by indication

8.3.2.5.    Spain

8.3.2.5.1.    Spain market size and forecast, by product and services

8.3.2.5.2.    Spain market size and forecast, by technology

8.3.2.5.3.    Spain market size and forecast, by application

8.3.2.5.4.    Spain market size and forecast, by indication

8.3.2.6.    Rest of Europe

8.3.2.6.1.    Rest of Europe market size and forecast, by product and services

8.3.2.6.2.    Rest of Europe market size and forecast, by technology

8.3.2.6.3.    Rest of Europe market size and forecast, by application

8.3.2.6.4.    Rest of Europe market size and forecast, by indication

8.3.3.    Europe market size and forecast, by product and services

8.3.4.    Europe market size and forecast, by technology

8.3.5.    Europe market size and forecast, by application

8.3.6.    Europe market size and forecast, by indication

8.4.    Asia-Pacific

8.4.1.    Key market trends and opportunities

8.4.2.    Market analysis by country

8.4.2.1.    Japan

8.4.2.1.1.    Japan market size and forecast, by product and services

8.4.2.1.2.    Japan market size and forecast, by technology

8.4.2.1.3.    Japan market size and forecast, by application

8.4.2.1.4.    Japan market size and forecast, by indication

8.4.2.2.    China

8.4.2.2.1.    China market size and forecast, by product and services

8.4.2.2.2.    China market size and forecast, by technology

8.4.2.2.3.    China market size and forecast, by application

8.4.2.2.4.    China market size and forecast, by indication

8.4.2.3.    Australia

8.4.2.3.1.    Australia market size and forecast, by product and services

8.4.2.3.2.    Australia market size and forecast, by technology

8.4.2.3.3.    Australia market size and forecast, by application

8.4.2.3.4.    Australia market size and forecast, by indication

8.4.2.4.    India

8.4.2.4.1.    India market size and forecast, by product and services

8.4.2.4.2.    India market size and forecast, by technology

8.4.2.4.3.    India market size and forecast, by application

8.4.2.4.4.    India market size and forecast, by indication

8.4.2.5.    South Korea

8.4.2.5.1.    South Korea market size and forecast, by product and services

8.4.2.5.2.    South Korea market size and forecast, by technology

8.4.2.5.3.    South Korea market size and forecast, by application

8.4.2.5.4.    South Korea market size and forecast, by indication

8.4.2.6.    Rest of Asia-Pacific

8.4.2.6.1.    Rest of Asia-Pacific market size and forecast, by product and services

8.4.2.6.2.    Rest of Asia-Pacific market size and forecast, by technology

8.4.2.6.3.    Rest of Asia-Pacific market size and forecast, by application

8.4.2.6.4.    Rest of Asia-Pacific market size and forecast, by indication

8.4.3.    Asia-Pacific market size and forecast, by product and services

8.4.4.    Asia-Pacific market size and forecast, by technology

8.4.5.    Asia-Pacific market size and forecast, by application

8.4.6.    Asia-Pacific market size and forecast, by indication

8.5.    LAMEA

8.5.1.    Key market trends and opportunities

8.5.2.    Market analysis by country

8.5.2.1.    Brazil

8.5.2.1.1.    Brazil market size and forecast, by product and services

8.5.2.1.2.    Brazil market size and forecast, by technology

8.5.2.1.3.    Brazil market size and forecast, by application

8.5.2.1.4.    Brazil market size and forecast, by indication

8.5.2.2.    Saudi Arabia

8.5.2.2.1.    Saudi Arabia market size and forecast, by product and services

8.5.2.2.2.    Saudi Arabia market size and forecast, by technology

8.5.2.2.3.    Saudi Arabia market size and forecast, by application

8.5.2.2.4.    Saudi Arabia market size and forecast, by indication

8.5.2.3.    South Africa

8.5.2.3.1.    South Africa market size and forecast, by product and services

8.5.2.3.2.    South Africa market size and forecast, by technology

8.5.2.3.3.    South Africa market size and forecast, by application

8.5.2.3.4.    South Africa market size and forecast, by indication

8.5.2.4.    Rest of LAMEA

8.5.2.4.1.    Rest of LAMEA market size and forecast, by product and services

8.5.2.4.2.    Rest of LAMEA market size and forecast, by technology

8.5.2.4.3.    Rest of LAMEA market size and forecast, by application

8.5.2.4.4.    Rest of LAMEA market size and forecast, by indication

8.5.3.    LAMEA market size and forecast, by product and services

8.5.4.    LAMEA market size and forecast, by technology

8.5.5.    LAMEA market size and forecast, by application

8.5.6.    LAMEA market size and forecast, by indication

CHAPTER 9:    COMPETITIVE LANDSCAPE

9.1.    INTRODUCTION

9.1.1.    MARKET PLAYER POSITIONING, 2018

9.2.    MARKET SHARE ANALYSIS OF TOP PLAYERS, 2018 (%)

9.3.    TOP WINNING STRATEGIES

9.4.    COMPETITIVE DASHBOARD

9.5.    COMPETITIVE HEATMAP

CHAPTER 10:    COMPANY PROFILES: BIOMARKER TECHNOLOGIES MARKET

10.1.    AGILENT TECHNOLOGIES, INC.

10.1.1.    Company overview

10.1.2.    Company snapshot

10.1.3.    Operating business segments

10.1.4.    Product type Portfolio

10.1.5.    Business performance

10.2.    BIO-RAD LABORATORIES, INC.

10.2.1.    Company overview

10.2.2.    Company snapshot

10.2.3.    Operating business segments

10.2.4.    Product type Portfolio

10.2.5.    Business performance

10.2.6.    Key strategic moves and developments

10.3.    F. HOFFMANN-LA ROCHE LTD.

10.3.1.    Company overview

10.3.2.    Company snapshot

10.3.3.    Operating business segments

10.3.4.    Product portfolio

10.3.5.    Business performance

10.3.6.    Key strategic moves and developments

10.4.    Illumina, Inc.

10.4.1.    Company overview

10.4.2.    Company snapshot

10.4.3.    Operating business segments

10.4.4.    Product Portfolio

10.4.5.    Business performance

10.5.    LI-COR, Inc.

10.5.1.    Company overview

10.5.2.    Company snapshot

10.5.3.    Operating business segments

10.5.4.    Product portfolio

10.6.    Merck KGAA

10.6.1.    Company overview

10.6.2.    Company snapshot

10.6.3.    Operating business segments

10.6.4.    Product portfolio

10.6.5.    Business performance

10.6.6.    Key strategic moves and developments

10.7.    PERKINELMER INC.

10.7.1.    Company overview

10.7.2.    Company snapshot

10.7.3.    Operating business segments

10.7.4.    Product Portfolio

10.7.5.    Business performance

10.8.    QIAGEN N.V.

10.8.1.    Company overview

10.8.2.    Company snapshot

10.8.3.    Product type portfolio

10.8.4.    Business performance

10.9.    Shimadzu Corporation

10.9.1.    Company overview

10.9.2.    Company snapshot

10.9.3.    Operating business segments

10.9.4.    Product portfolio

10.9.5.    Business performance

10.11.  Thermo Fisher Scientific, Inc.

10.11.1.  Company overview

10.11.2.  Company snapshot

10.11.3.  Operating business segments

10.11.4.  Product Portfolio

10.11.5.  Business performance

10.12.  Other Key Player Profile

10.12.1.  Key player snapshot

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?